Converting Oxycodone 10mg ER to Liquid Formulation
You cannot directly convert extended-release oxycodone tablets to a liquid formulation because oxycodone oral solution is only available as an immediate-release product, not extended-release. This requires a complete reformulation of the dosing regimen, not a simple conversion.
The Critical Problem
Extended-release oxycodone 10mg twice daily provides controlled, sustained opioid delivery over 12 hours. Oxycodone oral solution is immediate-release with a half-life of approximately 3.5 hours and reaches peak concentration in 1-2 hours 1. Switching formulations changes the entire pharmacokinetic profile and requires dose redistribution across the day.
Recommended Conversion Approach
Step 1: Calculate Total Daily Oxycodone Dose
- Current regimen: 10mg ER twice daily = 20mg total daily dose
Step 2: Convert to Immediate-Release Liquid
According to FDA labeling, when converting from extended-release to immediate-release formulations, the same total daily dose can be used but must be divided into more frequent dosing intervals 1.
Prescribe: Oxycodone oral solution 5mg every 6 hours (four times daily)
- This maintains the 20mg total daily dose
- Provides around-the-clock coverage appropriate for chronic pain 1
- Accounts for the 3-4 hour half-life of immediate-release oxycodone 1
Step 3: Critical Safety Considerations
Start conservatively and monitor closely. The FDA explicitly warns that "the relative bioavailability of oxycodone hydrochloride tablets compared to extended-release oxycodone is unknown, so conversion to extended-release tablets must be accompanied by close observation for signs of excessive sedation and respiratory depression" 1. This warning applies in reverse when converting FROM extended-release.
- Consider reducing the initial dose by 25-50% given incomplete cross-tolerance and individual pharmacokinetic variability 1
- A safer starting dose would be: Oxycodone oral solution 3-5mg every 6 hours
- Titrate upward based on pain control and adverse effects 1
Step 4: Provide Breakthrough Dosing
- Immediate-release liquid allows for supplemental doses for breakthrough pain
- Typical breakthrough dose: 10-15% of total daily dose (approximately 2-3mg) as needed 1
Important Caveats
Bioavailability differences: Oxycodone oral solution has similar bioavailability to immediate-release tablets (60-87%), but food increases absorption by 27% 1. Counsel patients on consistent administration relative to meals.
Dosing frequency burden: Moving from twice-daily to four-times-daily dosing significantly impacts adherence. Ensure the patient understands and can comply with the new schedule.
Current MME context: This patient is at 30 MME/day (20mg oxycodone × 1.5 conversion factor = 30 MME) 2. This is below the 50 MME/day threshold where CDC guidelines recommend careful reassessment, but any conversion still requires vigilant monitoring.
Volume measurement accuracy: Studies show volume losses occur during stock checks of viscous oral solutions 3. Ensure patients use appropriate oral syringes (not household spoons) for accurate dosing.